SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 84 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,151,000 | +79.0% | 123,683 | +0.9% | 0.00% | +50.0% |
| Q1 2019 | $643,000 | +18.0% | 122,553 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $545,000 | -46.7% | 122,553 | -3.2% | 0.00% | -33.3% |
| Q3 2018 | $1,023,000 | +15.1% | 126,663 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $889,000 | -51.3% | 126,663 | -1.2% | 0.00% | -60.0% |
| Q1 2018 | $1,824,000 | +65.4% | 128,198 | +1.8% | 0.01% | +66.7% |
| Q4 2017 | $1,103,000 | -15.8% | 125,887 | +12.5% | 0.00% | -25.0% |
| Q3 2017 | $1,310,000 | -14.1% | 111,923 | +2.5% | 0.00% | -20.0% |
| Q2 2017 | $1,525,000 | +7.3% | 109,168 | +5.4% | 0.01% | +25.0% |
| Q1 2017 | $1,421,000 | +84.1% | 103,540 | -3.8% | 0.00% | +33.3% |
| Q4 2016 | $772,000 | -42.9% | 107,680 | +20.7% | 0.00% | -40.0% |
| Q3 2016 | $1,352,000 | +143.2% | 89,200 | +58.2% | 0.01% | +150.0% |
| Q2 2016 | $556,000 | -28.0% | 56,400 | -2.7% | 0.00% | -33.3% |
| Q1 2016 | $772,000 | – | 57,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |